Sunniva Inc (CSE:SNN)


Sunniva Inc. is a Canadian Securities Exchange listed vertically integrated medical cannabis company based in Calgary, Alberta. The company is committed to becoming one of the lowest cost producers delivering safe, high-quality cannabis products and services at scale.

Stock Chart

Share Structure

As of April 27, 2017
Shares Issued 31,735,410
Warrants 1,996,240
Options 4,166,054
Convertible Notes 2,495,028
Fully Diluted 40,392,732

Investment Highlights

  • Uniquely positioned in the largest cannabis markets – California and Canada
  • Experienced Leadership Team with a track record in healthcare
    • Management and Board focused on creating significant shareholder value
  • Vital products and services across three operational business units:
    • State of the art purpose built greenhouse manufacturing facilities at scale
    • Specialized Cannabis Clinics
    • Quality Vaporization Devices
  • Revenues and cash flow from acquisitions of Natural Health Services and Vapor Connoisseur
  • Strategic real estate partner; non-dilutive construction financing allows for significant buildout
  • Regulatory Compliance in all operating jurisdictions

Other Information

1. Building World-Class Greenhouses to be compliant with cGMP standards

Featuring the latest in modern agri-technology, Sunniva’s initial California greenhouse and manufacturing campus design will adhere to cGMP level standards and is expected to produce over 120,000kg of premium medical cannabis yearly, after phases 1 and 2 are complete.

2. Access to the market – Natural Health Services Canada

As Canada’s largest network of cannabis clinics, NHS offers thousands of patients the guidance they need from qualified professionals who specialize in the endocannabinoid system.

3. An Industry Leader In Quality Vaporizers

As one of the industry’s leading providers of custom, private-label dry herb and oil vaporizers, Vapor Connoisseur is constantly innovating and finding new solutions for better products.

Management Profiles

Dr. Anthony Holler CHAIRMAN AND CEO

Dr. Anthony (Tony) Holler is the former CEO and founder of ID Biomedical, acquired in 2015 by Glaxo Smith Kline for $1.7 billion, and former Chairman of Corriente Resources Inc., sold for approximately $700 million to CRCC-Tongguan Investment Co. Tony is the current Chairman of CRH Medical Corp., a publicly traded company and serves as Sunniva’s Chief Executive Officer. His expertise includes strategic planning, mergers and acquisitions, and financing, with a singular focus on increasing shareholder value.


David Negus has joined Sunniva Inc. as Chief Financial Officer and is accountable for the administrative, financial and risk management operations of the Company. Mr. Negus most recently served as the CFO of Luvo, a forward-thinking food company. Prior to his role at Luvo, Mr. Negus was Vice President, Corporate Controller at lululemon and played an integral role in the development and build out of a finance team that supported the business from a private company to a multi-billion dollar international organization. Mr. Negus holds a CPA, CA designation.


As the former owner and CEO of Vida Wealth Management Bahamas, former investment advisor at Canaccord Wealth Management, and former partner at an Alberta brokerage firm managing capital in excess of $3 billion, Leith has a proven track record for success. He lends his expertise in corporate strategy, financing, and sourcing potential mergers and acquisitions.